Occurrence and Antifungal Susceptibility of Candida Species Isolated from Pregnant Women in a Tertiary Hospital
DOI:
https://doi.org/10.62050/ljsir2023.v1n2.230Keywords:
Candida, Prevalence, Pregnancy, Vulvovaginal, Bingham UniversityAbstract
Candida is the leading cause of infection among pregnant women. This study was aimed to determine the occurrence and antifungal susceptibility of Candida species isolated from apparently healthy pregnant women receiving antenatal care at Bingham University Teaching Hospital. High vaginal swab was inoculated onto Sabouraud Dextrose Agar and Gram staining was carried out. Candida isolates were sub- cultured on Himedia CHROM Candida differential agar and identified according to their color, morphology, and appearance. Disc antifungal susceptibility test was carried out using standard protocols. The occurrence rate of vulvovaginal candidiasis (VVC) in this study was 42.5%. In this study, Candia albicans was the most predominant Candida species (51.2%) isolated. Pregnant women within the age range of 20-24 years had the highest infection occurrence of 100% while the lowest occurrence of the infection (25%) was observed among women within the age range of 40-44 years. There was a significant relationship between age and VVC infection (P>0.05). In relation to trimester, pregnant women in the second trimester had a high infection rate of 87.5% while women in the third trimester had the least occurrence rate of 10.9%. There was a significant relationship between vulvovaginal candidiasis infection and trimester (P>0.05). All Candida species were resistant to the antifungal drugs tested except for Candida kefyr which was susceptible to fluconazole and voriconazole. Therefore, early diagnosis and appropriate treatment among pregnant women receiving antenatal care can reduce the infection and prevent complications during childbirth
Downloads
References
Anderson, M., Karasaz, A. and Friedland, S. (2004). Are vaginal symptoms ever normal? A review literature. Med. Gen. Med., 6(4), 49
Centre for Disease Control. Vulvovaginal Candidiasis. 2015 Date accessed: 30/04/2021. Available from www.cdc.gov
Buggio, L., Somigliana, E., Borghi, A. and Vercellini, P. (2019). Probiotics and vaginal microecology. BMC Women's Health, 19(1), 25. https://doi.org/10.1186/s12905-019-0723-4
Waikhom, S. D., Afeke, I., Kwawu, G. S., Hintermann, K. M., George, Y. O., Bengyella, L., … Japheth, A. O. (2020). Prevalence of Vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth, 20, 266. https://doi.org/10.1186/s12884-020-02963-3
Vijaya, D., Dhanalakshmi, T.A. and Kulkarni, S. (2014). Changing trends of Vulvovaginal candidiasis. J. Lab. Physicians, 6, 28-30. https://doi.org/10.4103/0974-2727.129087
Owen, M. K. and Clenney, T. L. (2004). Management of vaginitis. Amer. Family Physician, 70, 2125-2132
Nigerian Investment Promotion Commission (2021). Date accessed: 1/05/2021. Available from www.nipc.gov
Cavanaugh, B. M. (2003). Nurse’s Manual of Laboratory and Diagnostic Test (4th Edition), E. A Davis Company 1925 Arch Street, Philadelphia
Sobel, J. D., Faro, S., Force, R. W., Foxman B., Ledger, W. J., Nyirjesy, P. R., Reed, B. B. and Summers, P. R. (1998). Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol., 178(2), 203-211. https://doi.org/10.1016/s0002-9378(98)80001-x
National Committee for Clinical Laboratory Standards (2004). Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline. NCCLS document M44-A, NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA
Nnadi, D. C. and Singh, S. (2017). The prevalence of genital Candida species among pregnant women attending antenatal clinic in a tertiary health centre in North-west Nigeria. Sahel. Med. J., 20, 33-37. https://doi.org/10.4103/1118-8561.204333
Guzel, A. B., Ilki, M., Burgut, R., Urunsak, I. F. and Ozgunen, F. T. (2011). An evaluation of risk factors in pregnant women with Candida vaginitis and the diagnostic value of simultaneous vaginal and rectal sampling. Mycopathologia, 172(25), 36. https://doi.org/10.1007/s11046-011-9392-z
Nelson, M., Wanjiru, W. and Margaret, M. (2013). Prevalence of vaginal candidiasis and determination of the occurrence of Candida species in pregnant women attending the antenatal clinic of Thika District Hospital, Kenya. Open J. Med. Microbiol., 3(4), 264-272. https://doi.org/10.4236/ojmm.2013.34040
Altayyar, I. A., Alsanosi, A. S. and Osaman, N. A. (2016). Prevalence of vaginal candidiasis among pregnant women attending different gynaecological clinic at South Libya. E. J. Expt. Bio., 6, 25-29
Bitew, A. and Abebaw, Y. (2018). Vulvovaginal candidiasis: Species distribution of Candida and their antifungal susceptibility pattern. BMC Women Health, 18(1), 94. https://doi.org/10.1186/s12905-018-0607-z
Aleruchi, C., Adogo, L. Y., Nfongeh, J. F. and Ajide, B. (2020). Epidemics and susceptibility of drugs used on vulvovaginitis in women in four states of north central Nigeria. N. J. Mycol., 11, 223-232
Khan, M., Ahmed, J., Gul, A., Ikram, A. and Lalani, F.K. (2018) Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infect Drug Resist., 11, 447–56
Hashemi, S. E., Shokohi, T., Abastabar, M., Aslani, N., Ghadamzadeh, M. and Haghani, I. (2019). Species distribution and susceptibility profiles of Candida species isolated from Vulvovaginal candidiasis, emergence of C. lusitaniae. Curr. Med. Mycol., 5(4), 26-34. https://doi.org/10.18502/cmm.5.4.2062
Yadav, K. and Prakash, S. (2016). Prevalence of vulvovaginal candidiasis in pregnancy. Global J Med and Med Sci, 4 (1): 108-116
Christopher, M. A., Fabian, V. N., Ukponoobong, E. A. and Itoroobong, E. E. (2022). Prevalence of Vulvovaginal candidiasis in pregnant women attending antenatal clinic in Abak, South- South Nigeria. Microbe and Infect Dis., 3(3), 714-719. https://doi.org/10.21608/mid.2021.87167.1175
Bamniya, J. S., Pathan, M. I. and Ladola, H. M. (2022). Prevalence of vaginal infections in urban pregnant women attending obstetric unit at tertiary care hospital, Ahmedabad: A prospective study. J. South Asian Feder. Obst. Gyn., 14(1), 22–25. https://doi.org/10.5005/jp-journals-10006-2001
Ezeigbo, O. R., Anolue, F. C. and Nnadozie, I. A. (2015). Vaginal candidiasis infection among pregnant women in Aba, Abia State, Nigeria. British Journal of Medicine & Medical Research, 9(3), 1-6. https://doi.org/10.9734/BJMMR/2015/18264
Nkeiruka, J. D., Chizaram, W. N., Ogechi, J. I. and Emeka, O. (2021). Prevalence of candidiasis among female patients attending Federal Medical Centre Owerri, Imo State, Nigeria. GSC Adv. Res. and Rev., 09(01), 001–006
Alli, J. A., Okonko, I. O., Odu, N., Kolade, A. F. and Nwanze, J. C. (2011). Detection and prevalence of Candida isolates among patients in Ibadan, Southwestern Nigeria. J. Microbiol. Biotech. Res, 1(3), 176-184
Mucci, M. J., Cuestas, M. L., Landanburu, M. F. and Mujica, M. T. (2017). Prevalence of Candida albicans, Candida dubliniensis and Candida Africana in pregnant women with Vulvovaginal candidiasis, in Argentina. Ibero-American Magazine of Mycology, 34(2), 72–76. https://doi.org/10.1016/j.riam.2016.09.001
Shrestha, S. N., Tuladhar, S., Basnyat, G. P., Acharya, P., Shrestha, A. and Kumar, P. (2011). Prevalence of vaginitis among pregnant women attending Paropakar Maternity and Women’s Hospital, Thapathali, Kathmandu. Nepal Med. Col. J., 4(13), 293–296
Konadu, D. G., Owusu-Ofori, A., Yidana, Z., Boadu, F., Iddrisu, L. F. and Adu-Gyasi, D. (2019). Prevalence of Vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana. BMC Pregnancy and Childbirth, 19, 341. https://doi.org/10.1186/s12884-019-2488-z
Sangaré, I., Sirima, C., Bamba, S., Zida, A., Cissé, M. and Bazié, W. W. (2018). Prevalence of Vulvovaginal candidiasis in pregnancy at three health centres in Burkina Faso. Journal De Mycologie Medicale, 28(1), 186–192. https://doi.org/10.1016/j.mycmed.2017.08.006
Adogo, L. Y., Aleruchi, C. and Nfongeh, J. F. (2020). Incidence, virulence markers and antifungal susceptibility profile of Candida species among contraceptive users in Benue and Niger States, Nigeria. Nig. J. Microbiol., 34(2), 5333 – 5342
Tsega, A. and Mekonnen, F. (2019). Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos referral hospital, Northwest Ethiopia. BMC Pregnancy Childbirth, 19(1), 527. https://doi.org/10.1186/s12884-019-2494-1
Akah, P. A., Nnamani, C. E. and Nnamani, P. O. (2010). Prevalence and treatment outcome of Vulvovaginal candidiasis in pregnancy in a rural community in Enugu State, Nigeria. J. Med. Med. Sci., 1(10), 447-452
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Lafia Journal of Scientific and Industrial Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
